TRPV3 as a Therapeutic Target for Itch

    April 2012 in “ Journal of Investigative Dermatology ”
    Erika Yamamoto‐Kasai, Kohei Imura, Kiyoshi Yasui, Michitaka Shichijou, I Oshima, Tsutomu Hirasawa, Tsuneaki Sakata, Takeshi Yoshioka
    Studysummary This study suggests that TRPV3 may play a key role in dry skin-related itch, indicating potential for TRPV3 antagonists in treating pruritus resistant to histamine H1R antagonists.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the role of TRPV3 in itch using ICRTRPV3-/- mice and found that TRPV3 deletion significantly reduced spontaneous scratching behavior and nerve fiber density in the skin, despite no difference in dry skin development between TRPV3 knockout and wild-type mice. These findings suggested that TRPV3 played a crucial role in itch development and nerve sprouting in dry skin, indicating that TRPV3 antagonists could be a potential therapeutic option for managing pruritus in conditions like atopic dermatitis.
    Discuss this study in the Community →